Corinna Rosenbaum

Corinna Rosenbaum is an accomplished professional in the field of biomedical research and development, currently serving as Director (Co-Head) of R&D Transformation & Operations and Director of the Management Office at BioNTech SE since June 2018. Notably, Corinna managed the mRNA COVID-19 vaccine development program, leading a high-performing team through critical phases, including clinical development and regulatory submissions, culminating in the licensure of COMIRNATY®. Prior to BioNTech, Corinna held positions at University Hospital Würzburg as a Quality Management Representative and Postdoctoral Researcher, focusing on intestinal tissue culture models and obtaining DIN EN ISO 9001 certification. Corinna's academic background includes a Doctorate from the Graduate School of Life Sciences at the University of Würzburg and a Diplom in Biology from Julius Maximilians University of Würzburg.